Overview

Study to Evaluate the Efficacy and Safety of CKD-352

Status:
Completed
Trial end date:
2021-05-07
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and safety of CKD-352 in patients with dry eye disease
Phase:
Phase 3
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical